Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

@article{Breslin2020CoronavirusD2,
  title={Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals},
  author={N. Breslin and C. Baptiste and C. Gyamfi‐Bannerman and Russell S. Miller and Rebecca Martinez and K. Bernstein and Laurence E. Ring and R. Landau and S. Purisch and A. Friedman and K. Fuchs and D. Sutton and M. Andrikopoulou and Devon M. Rupley and Jean-Ju Sheen and J. Aubey and N. Zork and L. Moroz and M. Mourad and R. Wapner and L. Simpson and M. D'Alton and D. Goffman},
  journal={American Journal of Obstetrics \& Gynecology Mfm},
  year={2020},
  volume={2},
  pages={100118 - 100118}
}
Abstract The novel coronavirus 2019, or COVID-19, infection has rapidly spread through the New York metropolitan area since the first reported case in the state on March 1, 2020. New York currently represents an epicenter for COVID-19 infection in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early experience with seven COVID-positive patients in pregnancy, including two women who were diagnosed with COVID-19 following an asymptomatic initial… Expand

Paper Mentions

Observational Patient Registry Clinical Trial
Longitudinal prospective study in pregnant women withpositive serology or PCR for SARS-CoV-2 and indicationinvasive technique (amniocentesis or chorionic biopsy) that has the objective… Expand
ConditionsCovid19, Pregnancy Related
Interventional Clinical Trial
The purpose of this study is to assess safety and efficacy of progesterone for treatment of COVID-19 in hospitalized men.  
ConditionsCOVID-19, Sars-CoV2
InterventionDrug
COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice
TLDR
In this case series, COVID-19 in pregnant women had a very low morbidity and no mortality, and these preliminary results are encouraging for pregnant women during the CO VID-19 pandemic. Expand
Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks
TLDR
The asymptomatic positive SARS-CoV-2 test rate among an obstetric population in Philadelphia differed between two hospitals and was lower than described in other geographic regions, which supports the importance of institution-specific testing protocols. Expand
Universal screening for novel coronavirus disease 2019 (COVID‐19) for asymptomatic parturients: May not be beneficial at this time
TLDR
Universal testing for SARS CoV-2 the causative agent of COVID-19 has been recommended for all pregnant women in the current epicenter, New York City, but this may not be the solution to controlling its spread. Expand
Universal Testing of COVID-19 Infection on a New Orleans, LA Labor and Delivery Unit
TLDR
The results confirm the asymptomatic carrier rate is high and support the case for universal testing in high prevalence cities, as well as confirm the natural history of COVID-19 and evaluate obstetric and neonatal outcomes. Expand
SEROPREVALENCE AND CLINICAL SPECTRUM OF SARS-CoV-2 INFECTION IN THE FIRST VERSUS THIRD TRIMESTER OF PREGNANCY
TLDR
None of the 125 pregnant women with SARS-CoV-2 infection required critical care as compared to 9% reported in cases diagnosed with PCR, and the data confirm that COVID-19 is asymptomatic in the majority of pregnant women and illustrate the value of seroprevalence studies to capture the high proportion of asymPTomatic or mild infections. Expand
Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montréal
TLDR
Most pregnant patients with SARS-CoV-2 are asymptomatic or have mild symptoms of COVID-19, and universal testing of pregnant patients presenting to hospital should be strongly considered as an important measure to prevent in-hospital and community transmission of CO VID-19. Expand
Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan.
  • F. Qadri, F. Mariona
  • Medicine
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2020
TLDR
Pregnant women are believed to be at higher risk of Covid-19 infection in association with the known physiologic changes of the immune, cardiorespiratory and metabolic systems during pregnancy. Expand
Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy.
TLDR
A prospective case series of pregnant women admitted to Northwestern Memorial Hospital from April 8 to April 27, 2020, showed a 13.5% prevalence of SARS-CoV-2 infection among the 211 asymptomatic women tested, which is higher than the average for the U.S. epicenter of the pandemic. Expand
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020
TLDR
It is suggested that among women of reproductive age with COVID-19, pregnant women are more likely to be hospitalized and at increased risk for ICU admission and receipt of mechanical ventilation compared with nonpregnant women, but their risk for death is similar. Expand
A snapshot of the Covid-19 pandemic among pregnant women in France
TLDR
The course over time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in French women from the beginning of the pandemic until mid-April, the risk profile of women with respiratory complications, and short-term pregnancy outcomes are described, and the most vulnerable pregnant women, those with comorbidities, may benefit particularly from prevention measures such as a lockdown. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals
TLDR
A series of 43 test-confirmed cases of COVID-19 presenting to a pair of affiliated New York City hospitals over two weeks from March 13 to 27, 2020 are described. Expand
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
TLDR
There is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy, according to this small group of cases. Expand
COVID-19 in pregnancy: early lessons
Abstract As the worldwide incidence of coronavirus disease 2019 (COVID-19) rapidly increases, there remains limited information on COVID-19 in pregnancy. We present here our experience with anExpand
Coronavirus disease 2019 in pregnancy: early lessons
TLDR
Of the 7 patients, 5 presented with symptoms of coronavirus disease 2019, including cough, myalgias, fevers, chest pain, and headache, and 4 were admitted to the hospital, including 2 who required supportive care with intravenous hydration. Expand
Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.
TLDR
Pregnancy and childbirth did not aggravate the course of symptoms or CT features of COVID-19 pneumonia, and all the women in this study-some of whom did not receive antiviral drugs-achieved good recovery from COVID -19 pneumonia. Expand
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
TLDR
Severe maternal and neonatal complications were not observed in pregnant women with COVID-19 pneumonia who had vaginal delivery or caesarean section and the need of effective screening on admission is highlighted. Expand
Clinical Characteristics of Coronavirus Disease 2019 in China
TLDR
During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings. Expand
Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
  • N. Li, Lefei Han, +8 authors L. Yang
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
Severe maternal and neonatal complications were not observed in pregnant women with COVID-19 pneumonia who had vaginal delivery or caesarean section and the need of effective screening on admission is highlighted. Expand
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis
TLDR
Pregnancy and perinatal outcomes of Coronavirus (CoV) spectrum infections, and particularly COVID-19 disease due to SARS-COV-2 infection during pregnancy were reported, including miscarriage, preterm birth, pre-eclampsia, pre term prelabor rupture of membranes, fetal growth restriction, and mode of delivery. Expand
H1N1 2009 influenza virus infection during pregnancy in the USA
TLDR
Cases and deaths associated with pandemic H1N1 virus in pregnant women identified in the USA during the first month of the present outbreak lend support to the present recommendation to promptly treat pregnant women with H 1N1 influenza virus infection with anti-influenza drugs. Expand
...
1
2
3
...